CWA Asset Management Group Increases AbbVie Holdings

Investment firm adds over 11,000 shares of pharmaceutical company in Q4

Mar. 22, 2026 at 7:59am

Got story updates? Submit your updates here. ›

CWA Asset Management Group LLC, an institutional investor, increased its position in AbbVie Inc. (NYSE: ABBV) by 16.7% in the fourth quarter of 2025. The firm now owns 83,604 shares of the pharmaceutical company's stock, valued at $19.1 million.

Why it matters

This filing provides insight into the investment decisions of CWA Asset Management Group, a notable institutional investor. The increase in AbbVie holdings suggests the firm sees value and growth potential in the pharmaceutical company's stock.

The details

According to the 13F filing, CWA Asset Management Group added 11,964 shares of AbbVie during the fourth quarter, bringing its total position to 83,604 shares. AbbVie comprises 0.7% of the firm's overall portfolio, making it the 29th largest holding.

  • CWA Asset Management Group filed the 13F report on March 22, 2026, disclosing its Q4 2025 holdings.

The players

CWA Asset Management Group LLC

An institutional investment firm that manages assets for clients.

AbbVie Inc.

A global biopharmaceutical company that focuses on discovering, developing, and commercializing therapies for complex and chronic medical conditions.

Got photos? Submit your photos here. ›

The takeaway

This filing demonstrates CWA Asset Management Group's continued confidence in AbbVie's long-term growth prospects, as evidenced by the firm's increased stake in the pharmaceutical company during the fourth quarter of 2025.